A detailed history of Bridgefront Capital, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Bridgefront Capital, LLC holds 2,055 shares of NTRA stock, worth $343,719. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,055
Holding current value
$343,719
% of portfolio
0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$97.75 - $129.67 $200,876 - $266,471
2,055 New
2,055 $261,000
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $224,879 - $352,834
3,798 New
3,798 $347,000
Q3 2021

Nov 12, 2021

SELL
$100.17 - $126.36 $245,015 - $309,076
-2,446 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$86.05 - $119.72 $210,478 - $292,835
2,446 New
2,446 $278,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.